These findings suggest that hypoxia increases TRKB and BDNF expressions, and consequently functions in the tumor microenvironment as the autocrine activator of the BDNF/TRKB signal pathway, enabling tumor cell proliferation, invasion, metastasis, and survival after multiple rounds of chemotherapy. Here, BDNF is linked to neoplasm.